Lundbeck Limited, A Menarini Pharma, Bayer plc, HRA Pharma UK and GlaxoSmithKline breach the ABPI Code of Practice

Lundbeck Limited, A Menarini Pharma, Bayer plc, HRA Pharma UK and GlaxoSmithKline have each breached Clause 2 of the ABPI Code of Practice and are the subject of advertisements in the medical, pharmaceutical and nursing press.Lundbeck – Case AUTH/2617/7/13A Menarini – Case AUTH/2629/8/13Bayer plc – Case AUTH/2631/8/13For each sponsoring one or two speakers and paying for exhibition space at a meeting which was not primarily for educational purposes and the impression given by their involvement, each company was ruled in breach of the following clauses of the Code:Clause 2         - Bringing discredit upon, and reducing confidence in, the pharmaceutical industryClause 9.1      - Failing to maintain high standardsClause 19.1    - Failing to meet the requirements for meetings.HRA Pharma UK – Case AUTH/2624/8/13As a result of emails sent by a representative to a health professional regarding the provision of an emergency contraception service and the use of ellaOne (ulipristal acetate), HRA Pharma was ruled in breach of the following clauses of the Code:Clause 2         - Bringing discredit upon, and reducing confidence in, the pharmaceutical industryClause 7.2      - Making a misleading claimClause 7.10   - Making an exaggerated claimClause 8.2      - Disparaging a service provisionClause 9.1      - Failing to maintain high standardsClause 15.2   - Fail...

Source: PharmaGossip - March 2, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs